Vitexin suppresses the proliferation, angiogenesis and stemness of endometrial cancer through the PI3K/AKT pathway

References

• Abdelrahim M, Konduri S, Basha R, Philip PA, Baker CH. 2010. Angiogenesis: an update and potential drug approaches. Int J Oncol. 36:5–18.
   PubMed Web of Science ®Google Scholar
• An F, Wang S, Tian Q, Zhu D. 2015. Effects of orientin and vitexin from Trollius chinensis on the growth and apoptosis of esophageal cancer EC-109 cells. Oncol Lett. 10(4):2627–2633.
   PubMed Web of Science ®Google Scholar
• Bai M, Yuan M, Liao H, Chen J, Xie B, Yan D, Xi X, Xu X, Zhang Z, Feng Y. 2015. OCT4 pseudogene 5 upregulates OCT4 expression to promote proliferation by competing with miR-145 in endometrial carcinoma. Oncol Rep. 33(4):1745–1752.
   PubMed Web of Science ®Google Scholar
• Borghi SM, Carvalho TT, Staurengo-Ferrari L, Hohmann MS, Pinge-Filho P, Casagrande R, Verri WA Jr. 2013. Vitexin inhibits inflammatory pain in mice by targeting TRPV1, oxidative stress, and cytokines. J Nat Prod. 76(6):1141–1149.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Burke TW, Heller PB, Woodward JE, Davidson SA, Hoskins WJ, Park RC. 1990. Treatment failure in endometrial carcinoma. Obstet Gynecol. 75(1):96–101.
   PubMed Web of Science ®Google Scholar
• Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME, Singh N. 2022. Endometrial cancer. Lancet. 399(10333):1412–1428.
   PubMed Web of Science ®Google Scholar
• Dong L, Du M, Lv Q. 2019. Picropodophyllin inhibits type I endometrial cancer cell proliferation via disruption of the PI3K/Akt pathway. ABBS. 51(7):753–760.
   Google Scholar
• Emons G, Gründker C. 2021. The role of gonadotropin-releasing hormone (GnRH) in endometrial cancer. Cells. 10(2):292.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. 2015. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136(5):E359–E386.
   PubMed Web of Science ®Google Scholar
• He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, Li B. 2021. Targeting PI3K/Akt signal transduction for cancer therapy. Signal Transduct Target Ther. 6:1–17.
   PubMed Web of Science ®Google Scholar
• He J-D, Wang Z, Li S-P, Xu Y-J, Yu Y, Ding Y-J, Yu W-L, Zhang R-X, Zhang H-M, Du H-Y. 2016. Vitexin suppresses autophagy to induce apoptosis in hepatocellular carcinoma via activation of the JNK signaling pathway. Oncotarget. 7(51):84520–84532.
   PubMedGoogle Scholar
• Huang J, Zhou Y, Zhong X, Su F, Xu L. 2022. Effects of vitexin, a natural flavonoid glycoside, on the proliferation, invasion, and apoptosis of human U251 glioblastoma cells. Oxid Med Cell Longev. 2022:3129155.
   PubMed Web of Science ®Google Scholar
• Kitson S, Sivalingam VN, Bolton J, McVey R, Nickkho-Amiry M, Powell ME, Leary A, Nijman HW, Nout RA, Bosse T, et al. 2017. Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studies. Mod Pathol. 30(3):459–468.
   PubMed Web of Science ®Google Scholar
• Lee II, Kim JJ. 2014. Influence of AKT on progesterone action in endometrial diseases. Biol Reprod. 91(3):63–63.
   PubMed Web of Science ®Google Scholar
• Liu X, Jiang Q, Liu H, Luo S. 2019. Vitexin induces apoptosis through mitochondrial pathway and PI3K/Akt/mTOR signaling in human non-small cell lung cancer A549 cells. Biol Res. 52(1):1–7.
   PubMedGoogle Scholar
• Lu EM-C, Ratnayake J, Rich AM. 2019. Assessment of proliferating cell nuclear antigen (PCNA) expression at the invading front of oral squamous cell carcinoma. BMC Oral Health. 19(1):1–7.
   PubMed Web of Science ®Google Scholar
• Ma K, Wang K, Zhou Y, Liu N, Guo W, Qi J, Hu Z, Su S, Tang P, Zhou X. 2021. Purified vitexin compound 1 serves as a promising antineoplastic agent in ovarian cancer. Front Oncol. 11:734708.
   PubMed Web of Science ®Google Scholar
• Nishida N, Yano H, Nishida T, Kamura T, Kojiro M. 2006. Angiogenesis in cancer. Vasc Health Risk Manag. 2(3):213–219.
   PubMedGoogle Scholar
• Ouban A. 2021. Expression of SALL4 stemness marker in laryngeal squamous cell carcinomas (LSCCs) and its clinical significance. All Life. 14(1):799–808.
   Web of Science ®Google Scholar
• Ożarowski M, Karpiński TM. 2021. Extracts and flavonoids of Passiflora species as promising anti-inflammatory and antioxidant substances. Curr Pharm Des. 27(22):2582–2604.
   PubMed Web of Science ®Google Scholar
• Peng Y, Gan R, Li H, Yang M, McClements DJ, Gao R, Sun Q. 2021. Absorption, metabolism, and bioactivity of vitexin: recent advances in understanding the efficacy of an important nutraceutical. Crit Rev Food Sci Nutr. 61(6):1049–1064.
   PubMed Web of Science ®Google Scholar
• Posada IM, Lectez B, Sharma M, Oetken-Lindholm C, Yetukuri L, Zhou Y, Aittokallio T, Abankwa D. 2017. Rapalogs can promote cancer cell stemness in vitro in a galectin-1 and H-ras-dependent manner. Oncotarget. 8(27):44550–44566.
   PubMedGoogle Scholar
• Prasad S, Ramachandran S, Gupta N, Kaushik I, Srivastava SK. 2020. Cancer cells stemness: a doorstep to targeted therapy. Biochim Biophys Acta Mol Basis Dis. 1866(4):165424.
   PubMed Web of Science ®Google Scholar
• Ren L, Chen H, Song J, Chen X, Lin C, Zhang X, Hou N, Pan J, Zhou Z, Wang L, et al. 2019. MiR-454-3p-mediated Wnt/β-catenin signaling antagonists suppression promotes breast cancer metastasis. Theranostics. 9(2):449–465.
   PubMed Web of Science ®Google Scholar
• Seo HR, Jeong HE, Joo HJ, Choi SC, Park CY, Kim JH, Choi JH, Cui LH, Hong SJ, Chung S, et al. 2016. Intrinsic FGF2 and FGF5 promotes angiogenesis of human aortic endothelial cells in 3D microfluidic angiogenesis system. Sci Rep. 6(1):28832.
   PubMedGoogle Scholar
• Sobecki M, Mrouj K, Camasses A, Parisis N, Nicolas E, Llères D, Gerbe F, Prieto S, Krasinska L, David A, et al. 2016. The cell proliferation antigen Ki-67 organises heterochromatin. Elife. 5:e13722.
   PubMed Web of Science ®Google Scholar
• Van Nyen T, Moiola CP, Colas E, Annibali D. 2018. Modeling endometrial cancer: past, present, and future. Int J Mol Sci. 19:2348.
   PubMed Web of Science ®Google Scholar
• Wang J, Song T, Zhou S, Kong X. 2019. YAP promotes the malignancy of endometrial cancer cells via regulation of IL-6 and IL-11. Mol Med. 25(1):1–9.
   PubMedGoogle Scholar
• Wang S, Zhang Z, Qian W, Ji D, Wang Q, Ji B, Zhang Y, Zhang C, Sun Y, Zhu C, et al. 2018. Angiogenesis and vasculogenic mimicry are inhibited by 8-Br-cAMP through activation of the cAMP/PKA pathway in colorectal cancer. OTT. 11:3765–3774.
   Google Scholar
• Wang J, Zheng X, Zeng G, Zhou Y, Yuan H. 2014. Purified vitexin compound 1 inhibits growth and angiogenesis through activation of FOXO3a by inactivation of Akt in hepatocellular carcinoma. Int J Mol Med. 33(2):441–448.
   PubMed Web of Science ®Google Scholar
• Wei M, Wu Y, Liu H, Xie C. 2020. Genipin induces autophagy and suppresses cell growth of oral squamous cell carcinoma via PI3K/AKT/MTOR pathway. DDDT. 14:395–405.
   PubMed Web of Science ®Google Scholar
• Wei W, Ying X, Zhang W, Chen Y, Leng A, Jiang C, Liu J. 2014. Effects of vitexin-2″-O-rhamnoside and vitexin-4″-O-glucoside on growth and oxidative stress-induced cell apoptosis of human adipose-derived stem cells. J Pharm Pharmacol. 66(7):988–997.
   PubMed Web of Science ®Google Scholar
• Wu Z, Jeong J-H, Ren C, Yang L, Ding L, Li F, Jiang D, Zhu Y, Lu J. 2021. Fatty acid–binding protein 4 (FABP4) suppresses proliferation and migration of endometrial cancer cells via PI3K/Akt pathway. OTT. 14:3929–3942.
   Google Scholar
• Zhang J, Espinoza LA, Kinders RJ, Lawrence SM, Pfister TD, Zhou M, Veenstra TD, Thorgeirsson SS, Jessup JM. 2013. NANOG modulates stemness in human colorectal cancer. Oncogene. 32(37):4397–4405.
   PubMed Web of Science ®Google Scholar
• Zhao S, Guan X, Hou R, Zhang X, Guo F, Zhang Z, Hua C. 2020. Vitexin attenuates epithelial ovarian cancer cell viability and motility in vitro and carcinogenesis in vivo via p38 and ERK1/2 pathways related VEGFA. Ann Transl Med. 8(18):1139–1139.
   PubMed Web of Science ®Google Scholar
• Zhou P, Zheng Z-H, Wan T, Wu J, Liao C-W, Sun X-J. 2021. Vitexin inhibits gastric cancer growth and metastasis through HMGB1-mediated inactivation of the PI3K/AKT/mTOR/HIF-1α signaling pathway. J Gastric Cancer. 21(4):439.
   PubMed Web of Science ®Google Scholar